Alanine scan-guided synthesis and biological evaluation of analogues of culicinin D, a potent anticancer peptaibol
Graphical abstract
Section snippets
Funding
The authors wish to thank the Maurice Wilkins Centre for Molecular Biodiscovery and the Health Research Council of New Zealand (contract 18/219) for funding.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References (6)
- et al.
Synthesis and antiproliferative activity of culicinin D analogues containing simplified AHMOD-based residues
Eur J Med Chem
(2019) - et al.
Improved strategy for the synthesis of the anticancer agent culicinin D
Eur J Org Chem
(2015) - et al.
Improved synthesis of the unnatural amino acids AHMOD and AMD, components of the anticancer peptaibol culicinin D
J Org Chem
(2015)
There are more references available in the full text version of this article.
Cited by (8)
Synthesis and antiproliferative activity of C- and N-terminal analogues of culicinin D
2020, Bioorganic and Medicinal Chemistry LettersDiscovery of Biologically Optimized Polymyxin Derivatives Facilitated by Peptide Scanning and in Situ Screening Chemistry
2023, Journal of the American Chemical SocietyExploring Glycan Binding Specificity of Odorranalectin by Alanine Scanning Library
2022, European Journal of Organic ChemistryCatalytic Asymmetric Total Synthesis of Leucinostatin A
2021, Chemical Record
- e
Authors contributed equally.
© 2020 Elsevier Ltd. All rights reserved.